See All Slides - tctmd.com

Slides

Presentation TCT 2012

Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

Presenter: Carlos Mena

October 22, 2012

Presentation TCT 2012

Next-Generation of AAA EVAR Grafts: Iterative or Transformative?

Presenter: Robert Bersin

October 22, 2012

Presentation TCT 2012

Angiographic Evaluation to Determine Procedural Approach

Presenter: Ashish Pershad

October 22, 2012

Presentation TCT 2012

Importance of Adequately Powered Studies in Clinical Medicine: Case Studies

Presenter: Sanjay Kaul

October 22, 2012

Presentation TCT 2012

When Are Two Stents Not Needed for the Distal Left Main Bifurcation?

Presenter: David Hildick-Smith

October 22, 2012

Presentation TCT 2012

Real-world Integration of OR and Cath Lab Staff for TAVR Procedures

Presenter: Roel Pinzon

October 22, 2012

Presentation TCT 2012

Interventionalist to Interventionalist Referral for PCI: A Viable Specialty Triage Mechanism or Zone of Repugnance?

Presenter: M. Nicholas Burke

October 22, 2012

Presentation TCT 2012

Screening Patients for Clinical Trial Eligibility: The Painful but Essential Step

Presenter: David Cox

October 22, 2012

Presentation TCT 2012

Managing the Tortuous Arch

Presenter: Alberto Cremonesi

October 22, 2012

Presentation TCT 2012

US Perspective

Presenter: Roxana Mehran

October 22, 2012

Advertisement

Slides

Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

Next-Generation of AAA EVAR Grafts: Iterative or Transformative?

Angiographic Evaluation to Determine Procedural Approach

Importance of Adequately Powered Studies in Clinical Medicine: Case Studies

When Are Two Stents Not Needed for the Distal Left Main Bifurcation?

Real-world Integration of OR and Cath Lab Staff for TAVR Procedures

Interventionalist to Interventionalist Referral for PCI: A Viable Specialty Triage Mechanism or Zone of Repugnance?

Screening Patients for Clinical Trial Eligibility: The Painful but Essential Step

Managing the Tortuous Arch

US Perspective

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content